Explore 3 Stock Ideas & Industry Insights Download Free Report

News

FrontView REIT (NYSE: FVR) Lifts 2026 Investment Target, Secures $50.5M Equity

• FrontView REIT (NYSE: FVR) increases its 2026 investment target following stronger capital markets activity.

Vinay Lochav | 02 July 2026

Prosperity Bancshares (NYSE: PB) Closes $590 Million Stellar Bancorp Merger

• Prosperity Bancshares (NYSE: PB) completed its $590 million acquisition of Stellar Bancorp, finalized in early July.

Vinay Lochav | 02 July 2026

Patriot Gold Corp (OTC: PGOL) Announces Reverse Stock Split Plan

• Patriot Gold Corp has approved a reverse stock split of its common stock, subject to regulatory approval.

Vinay Lochav | 02 July 2026

Berto Acquisition Corp. II (NASDAQ: GUACU) to Split Units, Shares and Warrants Trade Separately Starting July 6

• Separate trading of shares and warrants begins on or about July 6, 2026.

Vinay Lochav | 02 July 2026

Cumberland Pharmaceuticals (NASDAQ: CPIX) Inc. Sells Drug Portfolio for $100 Million

• Cumberland Pharmaceuticals Inc. Has closed a $100 million transaction with Apotex for FDA-approved products.

Vinay Lochav | 02 July 2026

CareView Communications (CRVW) Prolongs Credit Agreement Maturity Date to 2026

• CareView Communications has successfully amended its Credit Agreement, extending the maturity date.

Vinay Lochav | 02 July 2026

Cadrenal Therapeutics (NASDAQ: CVKD) raises $3 million via pre‑funded and Series C warrants

• Pre‑funded warrants covering up to 960,000 common shares were sold at a combined price of $3.1249 per unit.

Vinay Lochav | 02 July 2026

Sprinklr (NYSE: CXM) Names Thomas Addis as Chief Revenue Officer Effective July 1, 2026

• Sprinklr (NYSE: CXM) disclosed on July 1, 2026 that Thomas Addis will assume the role of Chief Revenue Officer.

Vinay Lochav | 02 July 2026

Evergy (NASDAQ: EVRG) Unit Raises $350 Million in 5.3% Bonds Due 2036

• Evergy Kansas Central issued $350 million in first mortgage bonds carrying a 5.3% coupon, maturing in 2036.

Vinay Lochav | 02 July 2026

EXoZymes Inc. (NASDAQ: EXOZ) Raises $639K in Unit Sale

• The company will use the net proceeds of $565K to further develop its N-trans-caffeoyltyramine business and products.

Vinay Lochav | 02 July 2026
Support

Hi! How can we help you today?

Loading…